新北方公司与OpenAI合作,利用人工智能更快地发现药物并降低成本. Novo Nordisk partners with OpenAI to use AI for faster drug discovery and lower costs.

丹麦制药公司Novo Nordisk与OpenAI合作, 加快药物发现和改进运营. Danish pharmaceutical company Novo Nordisk has partnered with OpenAI to accelerate drug discovery and improve operations. 通过人工智能分析大量生物数据集,旨在更快速有效地识别新药候选物,同时降低开发成本. The collaboration uses artificial intelligence to analyze vast biological datasets, aiming to identify new drug candidates more quickly and efficiently while reducing development costs. 这种合作包括研发和制造领域的培训计划和试点项目. The partnership includes training programs and pilot programs across research and manufacturing.